Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in idiopathic pulmonary fibrosis
2008-006054-17Phase 2Completed
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) comparing Macitentan with Placebo (2 arms). Started Mar 2009; status: completed.
02
Drugs
macitentan
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2008-006054-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006054-17.